Cannabinoid-1 receptor antagonist rimonabant (SR141716)...

Addiction Biology 2012 Vol. aop; Iss. aop

Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

Cleo L. Crunelle, Elsmarieke van de Giessen, Sybille Schulz, Louk J. M. J. Vanderschuren, Kora de Bruin, Wim van den Brink, Jan Booij
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
aop
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1369-1600.2011.00369.x
File:
PDF, 349 KB
english, 2012
Conversion to is in progress
Conversion to is failed